Document is current
Any future updates will be listed below
-
Authors
Hayashi, Yu
Okumura, Hiroki
Arioka, Yuko https://orcid.org/0000-0002-1792-8812
Kushima, Itaru https://orcid.org/0000-0002-0018-5178
Mori, Daisuke https://orcid.org/0000-0002-9072-2546
Lo, Tzuyao
Otgonbayar, Gantsooj
Kato, Hidekazu https://orcid.org/0000-0001-9995-504X
Nawa, Yoshihiro https://orcid.org/0000-0003-3164-2519
Kimura, Hiroki
Aleksic, Branko https://orcid.org/0000-0001-8982-4580
Ozaki, Norio https://orcid.org/0000-0002-7360-4898
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21wm0425007)
Japan Agency for Medical Research and Development (JP19dm0207075)
Japan Agency for Medical Research and Development (JP19ak0101113)
Japan Agency for Medical Research and Development (JP21dk0307103)
Japan Agency for Medical Research and Development (JP22ek0109601)
Japan Agency for Medical Research and Development (JP22tm0424222)
- License Information
-
More Information
Article History
Received: 14 February 2023
Revised: 19 May 2024
Accepted: 23 May 2024
First Online: 3 June 2024
Competing interests
: Dr. N. Ozaki has received research support or speakers’ honoraria from or has served as a joint researcher with, or a consultant to, Sumitomo Pharma, Otsuka, Viatris, Eisai, Mochida, Kyowa Pharmaceutical Industry, Nihon Medi-Physics, Nippon Chemiphar, Medical Review, Nippon Boehringer Ingelheim, SUSMED, outside the submitted work.
: This study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Nagoya University (approval number: 2012-0184). All subjects provided written informed consent.
